David LinetskyPoint-of-Care Marketing
Bud BilanichSuccess Coach
Matt TurnerPatient Affordability
Matthew DurhamOmnidynamic Marketing
Frank BurrellScientific Storytelling
Daniel SontupeMarket Access
Paul TheisenPatient Acquisition
Stacey GandlerBrand Nourishment
Liz KaneImpactful Strategy
Suma Ramadas, PhDMedical Affairs
Pat PurcellMeeting Engagement
Amy GilesIncreasing Engagement
Joey CohenMedication Adherence
Brenda SnowAuthentic Patient Voice
Press ReleaseSource: Sanofi (EURONEXT: SAN) (NYSE: SNY) Dupixent® (dupilumab) showed positive Phase 3 ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email